Camidanlumab tesirine Uses, Dosage, Side Effects and more
Camidanlumab tesirine is under investigation in clinical trial NCT04639024 (ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN).
Trade Name | Camidanlumab tesirine |
Generic | Camidanlumab tesirine |
Camidanlumab tesirine Other Names | Camidanlumab tesirine |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |